Crux Biomedical

Crux Biomedical, located in Menlo Park, California, is dedicated to developing improved therapies for the human vascular system. The company has developed the highly differentiated Crux VCF System, an inferior vena cava (IVC) filter for the treatment of pulmonary embolism (PE).